USD 190.97
(-2.88%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 7.39 USD | 26.98% |
2022 | 5.82 USD | 15.25% |
2021 | 5.05 USD | 245.89% |
2020 | 1.46 USD | 48.98% |
2019 | 0.98 USD | -22.83% |
2018 | 1.27 USD | -78.87% |
2017 | 6.01 USD | 680.52% |
2016 | 0.77 USD | -75.56% |
2015 | 3.15 USD | 13.31% |
2014 | 2.78 USD | 51.91% |
2013 | 1.83 USD | 28.87% |
2012 | 1.42 USD | -26.42% |
2011 | 1.93 USD | 50.78% |
2010 | 1.28 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | 1.58 USD | -38.76% |
2024 Q2 | 1.99 USD | 25.95% |
2024 Q3 | 1.57 USD | -21.11% |
2023 Q4 | 2.58 USD | 55.42% |
2023 Q3 | 1.66 USD | 3.11% |
2023 FY | - USD | 26.98% |
2023 Q1 | 1.56 USD | 27.87% |
2023 Q2 | 1.61 USD | 3.21% |
2022 Q4 | 1.22 USD | -19.74% |
2022 Q3 | 1.52 USD | 11.76% |
2022 Q2 | 1.36 USD | -20.47% |
2022 FY | - USD | 15.25% |
2022 Q1 | 1.71 USD | 2.4% |
2021 Q1 | 1.11 USD | 79.03% |
2021 Q2 | 0.91 USD | -18.02% |
2021 Q3 | 1.36 USD | 49.45% |
2021 Q4 | 1.67 USD | 22.79% |
2021 FY | - USD | 245.89% |
2020 Q4 | 0.62 USD | 16.98% |
2020 Q3 | 0.53 USD | 541.67% |
2020 Q2 | -0.12 USD | -127.91% |
2020 Q1 | 0.43 USD | 377.78% |
2020 FY | - USD | 48.98% |
2019 Q2 | 0.31 USD | 6.9% |
2019 FY | - USD | -22.83% |
2019 Q4 | 0.09 USD | -68.97% |
2019 Q3 | 0.29 USD | -6.45% |
2019 Q1 | 0.29 USD | -14.71% |
2018 Q4 | 0.34 USD | 13.33% |
2018 Q2 | 0.30 USD | -9.09% |
2018 FY | - USD | -78.87% |
2018 Q1 | 0.33 USD | -93.58% |
2018 Q3 | 0.30 USD | 0.0% |
2017 Q2 | 0.35 USD | 9.37% |
2017 Q4 | 5.14 USD | 1217.95% |
2017 Q1 | 0.32 USD | 142.67% |
2017 Q3 | 0.39 USD | 11.43% |
2017 FY | - USD | 680.52% |
2016 FY | - USD | -75.56% |
2016 Q3 | 0.83 USD | 13.7% |
2016 Q2 | 0.73 USD | -17.98% |
2016 Q1 | 0.89 USD | 3.49% |
2016 Q4 | -0.75 USD | -190.36% |
2015 Q1 | 0.69 USD | -1.43% |
2015 Q4 | 0.86 USD | -5.49% |
2015 Q3 | 0.91 USD | 31.88% |
2015 Q2 | 0.69 USD | 0.0% |
2015 FY | - USD | 13.31% |
2014 Q3 | 0.73 USD | 10.61% |
2014 Q2 | 0.66 USD | -4.35% |
2014 Q1 | 0.69 USD | 23.21% |
2014 FY | - USD | 51.91% |
2014 Q4 | 0.70 USD | -4.11% |
2013 Q4 | 0.56 USD | 7.69% |
2013 Q1 | 0.37 USD | 32.14% |
2013 FY | - USD | 28.87% |
2013 Q2 | 0.31 USD | -16.22% |
2013 Q3 | 0.52 USD | 67.74% |
2012 FY | - USD | -26.42% |
2012 Q1 | 0.34 USD | 0.0% |
2012 Q4 | 0.28 USD | -33.33% |
2012 Q2 | 0.38 USD | 11.76% |
2012 Q3 | 0.42 USD | 10.53% |
2011 FY | - USD | 50.78% |
2010 FY | - USD | 0.0% |
2001 Q3 | 1.52 USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Agilent Technologies, Inc. | 4.22 USD | -75.118% |
Charles River Laboratories International, Inc. | 9.27 USD | 20.28% |
Quest Diagnostics Incorporated | 7.59 USD | 2.635% |
Danaher Corporation | 6.44 USD | -14.752% |
Enzo Biochem, Inc. | -0.51 USD | 1549.02% |
Laboratory Corporation of America Holdings | 4.80 USD | -53.958% |
Mettler-Toledo International Inc. | 36.10 USD | 79.529% |
Qiagen N.V. | 1.54 USD | -379.87% |
Revvity, Inc. | 5.56 USD | -32.914% |
Thermo Fisher Scientific Inc. | 15.53 USD | 52.415% |
Waters Corporation | 10.87 USD | 32.015% |